Marinus Pharmaceuticals is a company of dedicated individuals committed to developing effective treatments for neurological disorders. Marinus is excited to advance ganaxolone in clinical trials to further epilepsy, posttraumatic stress disorder and Fragile-X research. Below are additional resources for general information on epilepsy, poasttraumattic stress disorder and Fragile-X syndrome:

Here are additional resources for patients:

General Epilepsy Information Resources:

The Centers for Disease Control and Prevention
» http://www.cdc.gov/Epilepsy

National Institute of Neurological Disorders and Stroke ‘
» http://www.ninds.nih.gov/disorders/epilepsy

The Epilepsy Project
» http://www.epilepsy.org

Posttraumattic Stress Disorder

Fragile-X Syndrome

The National Fragile-X Foundation
» http://www.nfxf.org/html/home.shtml

The Centers for Disease Control and Prevention
» http://www.cdc.gov/ncbddd/single_gene/fragilex.htm

Patient Resources:

To search for current ongoing clinical trials please visit http://www.clinicaltrials.gov